MedTrace Logo

Clinical Study to Evaluate the Efficacy of Blood Purification Therapy on Cholesterol Crystal Embolism

NCT01726868 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2016-07-04

No results posted yet for this study

Summary

The aim of this study is to evaluate efficacy and safety of blood purification therapy on renal dysfunction by cholesterol crystal embolism.

Conditions

  • Cholesterol Embolism

Interventions

DEVICE

Liposorber LA-15 System

Six sessions of blood purification treatment with Liposorber LA-15 System.

Sponsors & Collaborators

  • Japan Community Health Care Organization Sendai Hospital

    lead OTHER

Principal Investigators

  • Toshinobu Sato, MD, PhD · Japan Community Health Care Organization Sendai Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2019-12-31
Completion
2020-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01726868 on ClinicalTrials.gov